In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation

Blood Cells, Molecules and Diseases

Volumn 24, Issue 2, 1998, Pages 262-270

  Beghini, Alessandro ^b   Cairoli, Roberto ^a   Morra, Enrica ^a   Larizza, Lidia ^b  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b Department of Biology and Genetics ^*

Author keywords

Activating mutation; C kit; Differentiation; Ligand independence; Mast cells

Indexed keywords

STEM CELL FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; GENE MUTATION; HUMAN; HUMAN CELL; MAST CELL; MASTOCYTOMA; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE;

EID: 0032104728     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1006/bcmd.1998.0191     Document Type: Article

References (29)

1. 1. Yarden Y, Ullrich A. Growth factor receptor tyrosine kinases. Annu Rev Biochem 57:443, 1988.
2. 2. Ullrich A, Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212, 1990.
3. 3. Lorenz U, Bergemann AD, Steinberg HN, et al. Genetic analysis reveals cell type-specific regulation of receptor tyrosine kinase c-kit by the protein tyrosine phosphatase SHP1. J Exp Med 184:1111-1126, 1996.
4. 4. Ikeda H, Kanakura Y, Tamaki T, et al. Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells. Blood 78:2962-2968, 1991.
5. 5. Kuriu A, Ikeda H, Kanakura Y, et al. Proliferation of human myeloid leukemia cell line associated with the tyrosine-phosphorylation and activation of the protooncogene c-kit product. Blood 78:2834, 1991.
6. 6. Ratajczak MZ, Luger SM, DeRiel K, Abrahm J, Calabretta B, Gewirtz AM. Role of the KIT protooncogene in normal and malignant human hematopoiesis. Proc Natl Acad Sci USA 89:1710-1714, 1992.
7. 7. Valent P, Spanblochl E, Sperr WR, et al. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long term-culture. Blood 80:2237-2245, 1992.
8. 8. Tsujimura T. Role of c-kit receptor tyrosine kinase in the development, survival and neoplastic transformation of mast cells. Pathol Int 46:933,1996
9. + bone marrow progenitor cells. J Immunol 146:1410-1415, 1991.
10. 10. Agis H, Willheim M, Sperr ,auWR, et al. Monocytes not make mast cells when cultured in the presence of SCF. J Immunol 151:4221-4227, 1993.
11. 11. Valent P, Spanblochl E, Bankl HC, et al. Kit ligand/ mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis. Blood 84:4322-4332, 1994.
12. 12. Kanakura Y, Furitsu T, Tsujimura T, et al. Activating mutations of the c-kit proto-oncogene in a human mast cell leukemia cell line. Leukemia 8(Suppl 1):S18, 1994.
13. 13. Furitsu T, Tsujimura T, Tono T, et al. Identification of mutations in the coding sequence of the protooncogene c-kit in a human mast cell leukemia cell line causing ligand independent activation of c-kit product. J Clin Invest 92: 1736-1744, 1993.
14. 14. Nakata Y, Kimura A, Katoh O, et al. C-kit point mutation of extracellular domain in patients with myeloproliferative disorders. Br J Haematol 91:661-663, 1995.
15. 15. Kiss C, Cesano A, Zsebo KM, Clark SC, Santoli D. Human stem cell factor (c-kit ligand) induces an autocrine loop of growth in a GM-CSF-dependent megakaryocytic leukemia cell line. Leukemia 7:235-240, 1993.
16. 16. Tsujimura T, Furitsu T, Morimoto M, et al. Ligand-independent activation of c-kit receptor tyrosine kinase in a murine mastocytoma cell line P-815 generated by a point mutation. Blood 83: 2619-2626, 1994.
17. 17. Nagata H, Worobec AS, Oh CK, et al. Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci USA 92:10560-10564, 1995.
18. 18. Pignon JM, Giraudier S, Duquesnoy P, et al. A new c-kit mutation in a case of aggressive mast cell disease. Br J Haematol 96:374-376, 1997.
19. 19. Longley BJ, Tyrrell L, Lu SZ, et al. Somatic c-kit activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm. Nat Genet 12: 312-314, 1996.
20. 20. Kitayama H, Tsujimura T, Matsumura I, et al. Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase. Blood 88:995, 1996
21. 21. Piao X, Bernstein A. A point mutation in the catalytic domain of c-kit induces growth factor independence, tumorigenicity, and differentiation of mast cells. Blood 87:3117-3123, 1996.
22. 22. Spritz RA, Giebel LB, Holmes SA. Dominant negative and loss of function mutations of the c-kit (mast/stem cell growth factor receptor) proto-oncogene in human piebaldism. Am J Hum Genet 50:261-269, 1992.
23. 23. Sheffield VC, Cox DR, Lerman LS, Myers RM. Attachment of a 40-base-pair G+C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes. Proc Natl Acad Sci USA 86:232-236, 1989.
24. 24. Fischer SG, Lerman LS: DNA fragments differing by single base-pair substitutions are separated in denaturing gradient gels: correspondence with melting theory. Proc Natl Acad Sci USA 80: 1579, 1983.
25. 25. Tsujimura T, Furitsu T, Morimoto M, et al. Substitution of an aspartic acid results in constitutive activation of c-kit receptor tyrosine kinase in a rat tumor mast cell line RBL-2H3. Int Arch Allergy Immunol 106(4):377-385, 1995.
26. 26. Piao X, Paulson R, van der Geer P, Pawson T, Bernstein A. Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP-1.Proc Natl Acad Sci USA 93: 14665-14669, 1996.
27. 27. Kita K, Shirakawa S, Kamada N. Cellular characteristics of acute myeloblastic leukemia associated with t(8;21) (q22;q22). Leuk Lymphoma 13: 229-234, 1994.
28. 28. Schmidt L, ,ausDuh FM, Chen F, et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 16: 68-73, 1997.
29. 29. Bianchi AB, Aldaz CM, Conti CJ. Nonrandom duplication of the chromosome bearing a mutated Ha-ras-1 allele in mouse skin tumors. Proc Natl Acad Sci USA 87: 6902-6906, 1990.